Physicians have long warned patients against gaining significant weight, telling them that too much could cause cardiovascular disease. But new research shows that even a little weight, as little as 5 percent, could make a difference in one’s heart health.

In a new study, researchers at Duke University set out to explore how many patients who regularly smoke and are hospitalized for a heart attack receive cessation medications at discharge.

First responders and survivors at the World Trade Center during the terrorist attacks of Sept. 11, 2001, were exposed to hazardous materials. A new study in the journal Injury Epidemiology examines what impact this had on rates of asthma, diabetes and heart and lung disease.

A team from the University of Colorado (UC) in Boulder and Vanderbilt Heart and Vascular Institute in Tennessee published a study of the impact of polypharmacy in patients with heart failure in Clinical Interventions in Aging.

In a series of late-breaking trials being presented at the Asian Pacific Society of Cardiology’s (APSC) meeting in Singapore, research is surfacing about the realities of heart failure in Asian countries.

A new study conducted by researchers at Weill Cornell Medical College in New York shows that black patients are twice as likely as white counterparts to die from an initial heart event, suggesting heart attack prevention among blacks should be emphasized.

New research may show why some heart failure patients don’t respond to beta-blocker drugs—with the cause lying in the dysfunction of beta-adrenergic receptor 3 (β3AR) and resulting decreases in cardioprotective phospholipid.

Though the rate of heart failure hospitalizations has decreased over the last few years in the U.S., black Americans are still admitted at a higher rate than other ethnic and racial groups, according to a new study from the University of California, Los Angeles.